Ved at blokere BCR- ABL- kinase samt andre kinaser medvirker Sprycel til at begrænse spredningen af leukæmicellerne.
By blocking BCR-ABL kinase, as well as other kinases, Sprycel helps to control the spread of leukaemia cells.